Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXLL8F
|
||||
Drug Name |
(2-(benzo[b]thiophen-3-yl)cyclopropyl)-N,N-dimethylmethanamine
|
||||
Synonyms |
CHEMBL249161
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C14H17NS
|
||||
Canonical SMILES |
CN(C)CC1CC1c2csc3ccccc23
|
||||
InChI |
InChI=1S/C14H17NS/c1-15(2)8-10-7-12(10)13-9-16-14-6-4-3-5-11(13)14/h3-6,9-10,12H,7-8H2,1-2H3
|
||||
InChIKey |
AQBBMDYZYWMBQN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.